The pathogenesis of lung disease in rheumatoid arthritis (RA) has stil
l to be defined. Risk factors associated with lung involvement in RA w
ere investigated by means of pulmonary function studies in 40 RA patie
nts without apparent lung disease. A decreased carbon monoxide (CO) di
ffusion capacity indicative of interstitial lung disease (ILD) was the
main pulmonary function defect found in the first 20 patients. The oc
currence was associated with current cigarette smoking. This associati
on was confirmed in a case control study performed subsequently. These
data suggest that ILD in RA is stimulated by smoking and provide an a
dditional argument that modification of smoking behaviour in RA patien
ts might lead to less severe complications.